Feedback / Questions
bosakitug (BSI-045B) - Aclaris
https://www.globenewswire.com/news-release/2025/06/02/3091709/37216/en/Aclaris-Therapeutics-Initiates-Phase-2-Trial-of-Bosakitug-ATI-045-in-Atopic-Dermatitis.html
Jun 2, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next